EventBusinessNovember 16, 2026

CataX AI raises RMB 40 million seed round for clinical drug development agents

Read original source →technode.com

Qiming Venture Partners incubated Shanghai-based CataX AI and was the sole investor in the RMB 40 million round. Its "Clinical-of-One" model pairs a clinical lead with AI agents that review research, draft documents and process data, with human experts making key decisions.

People · Wang Zilong

1 source

More stories today

Open the live feed